CalciMedica (CALC) Competitors $3.27 +0.01 (+0.18%) As of 03:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CALC vs. SXTC, FTLF, TARA, IPHA, CRBP, GNLX, AVTX, FBRX, MIST, and MCRBShould you be buying CalciMedica stock or one of its competitors? The main competitors of CalciMedica include China SXT Pharmaceuticals (SXTC), FitLife Brands (FTLF), Protara Therapeutics (TARA), Innate Pharma (IPHA), Corbus Pharmaceuticals (CRBP), Genelux (GNLX), Avalo Therapeutics (AVTX), Forte Biosciences (FBRX), Milestone Pharmaceuticals (MIST), and Seres Therapeutics (MCRB). These companies are all part of the "pharmaceutical products" industry. CalciMedica vs. Its Competitors China SXT Pharmaceuticals FitLife Brands Protara Therapeutics Innate Pharma Corbus Pharmaceuticals Genelux Avalo Therapeutics Forte Biosciences Milestone Pharmaceuticals Seres Therapeutics CalciMedica (NASDAQ:CALC) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends. Does the media prefer CALC or SXTC? In the previous week, CalciMedica and CalciMedica both had 3 articles in the media. CalciMedica's average media sentiment score of 0.95 beat China SXT Pharmaceuticals' score of 0.83 indicating that CalciMedica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CalciMedica 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive China SXT Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CALC or SXTC? CalciMedica has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Do analysts rate CALC or SXTC? CalciMedica currently has a consensus price target of $16.00, suggesting a potential upside of 389.90%. Given CalciMedica's stronger consensus rating and higher possible upside, equities analysts clearly believe CalciMedica is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CalciMedica 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00China SXT Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is CALC or SXTC more profitable? China SXT Pharmaceuticals' return on equity of 0.00% beat CalciMedica's return on equity.Company Net Margins Return on Equity Return on Assets CalciMedicaN/A -206.51% -103.81% China SXT Pharmaceuticals N/A N/A N/A Do insiders & institutionals hold more shares of CALC or SXTC? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 41.6% of CalciMedica shares are held by insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, CALC or SXTC? China SXT Pharmaceuticals has higher revenue and earnings than CalciMedica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalciMedicaN/AN/A-$13.70M-$1.60-2.04China SXT Pharmaceuticals$1.74M95.69-$3.30MN/AN/A SummaryChina SXT Pharmaceuticals beats CalciMedica on 6 of the 11 factors compared between the two stocks. Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CALC vs. The Competition Export to ExcelMetricCalciMedicaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.63M$3.37B$6.05B$10.51BDividend YieldN/A2.31%5.73%4.82%P/E Ratio-2.0422.2185.5327.36Price / SalesN/A472.84592.56135.63Price / CashN/A44.9825.7730.18Price / Book3.0510.4612.696.79Net Income-$13.70M-$52.58M$3.32B$276.59M7 Day Performance-3.66%1.15%0.58%1.08%1 Month Performance3.03%14.95%9.50%8.50%1 Year Performance-18.15%21.65%79.27%44.54% CalciMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CALCCalciMedica2.5389 of 5 stars$3.27+0.2%$16.00+389.9%-14.4%$45.63MN/A-2.0430News CoverageSXTCChina SXT Pharmaceuticals0.3841 of 5 stars$1.63-0.4%N/A-68.2%$189.59M$1.74M0.0090Gap DownFTLFFitLife Brands3.8966 of 5 stars$20.06+1.6%$23.00+14.7%+26.0%$188.38M$63.05M23.8820TARAProtara Therapeutics2.1631 of 5 stars$4.82-1.0%$19.60+306.6%+217.9%$185.97MN/A-2.9830IPHAInnate Pharma3.1489 of 5 stars$1.96-0.8%$6.50+231.6%-6.8%$180.68M$6.00M0.00220Gap UpCRBPCorbus Pharmaceuticals3.8619 of 5 stars$14.61+0.6%$45.43+210.9%-13.1%$179.05MN/A-3.0740GNLXGenelux1.2604 of 5 stars$4.71+3.7%$20.33+331.7%+101.1%$177.90M$10K-5.4810AVTXAvalo Therapeutics3.2006 of 5 stars$13.48-3.7%$31.67+134.9%+43.3%$177.26M$440K0.0040Analyst ForecastFBRXForte Biosciences2.6703 of 5 stars$14.23-1.4%$68.00+377.9%+224.2%$176.92MN/A-0.875MISTMilestone Pharmaceuticals2.0928 of 5 stars$2.08-1.9%$4.50+116.3%+37.2%$176.79MN/A-2.4830MCRBSeres Therapeutics2.1804 of 5 stars$20.09-4.3%$14.33-28.7%+19.2%$175.79M$126.32M-4.37330News CoveragePositive News Related Companies and Tools Related Companies China SXT Pharmaceuticals Alternatives FitLife Brands Alternatives Protara Therapeutics Alternatives Innate Pharma Alternatives Corbus Pharmaceuticals Alternatives Genelux Alternatives Avalo Therapeutics Alternatives Forte Biosciences Alternatives Milestone Pharmaceuticals Alternatives Seres Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CALC) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
